Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-03 Loerop James Chief Business Officer Exercise or conversion +20,875 198,197
2026-02-03 Loerop James Chief Business Officer Shares withheld for taxes −5,937 $3.47 $21K 192,260
2026-02-03 Loerop James Chief Business Officer Exercise or conversion · Restricted Stock Units −20,875 62,625
2026-02-02 Loerop James Chief Business Officer Grant or award · Restricted Stock Units +97,700 97,700
2026-02-02 Loerop James Chief Business Officer Grant or award · Employee Stock Option (Right to Buy) +341,900 341,900
2026-02-01 Loerop James Chief Business Officer Exercise or conversion +11,250 165,758
2026-02-01 Loerop James Chief Business Officer Exercise or conversion +7,500 173,258
2026-02-01 Loerop James Chief Business Officer Exercise or conversion +14,750 188,008
2026-02-01 Loerop James Chief Business Officer Shares withheld for taxes −10,686 $3.51 $38K 177,322
2026-02-01 Loerop James Chief Business Officer Exercise or conversion · Restricted Stock Units −11,250 0
2026-02-01 Loerop James Chief Business Officer Exercise or conversion · Resticted Stock Units −7,500 7,500
2026-02-01 Loerop James Chief Business Officer Exercise or conversion · Restricted Stock Units −14,750 29,500
2026-01-02 Loerop James Chief Business Officer Exercise or conversion +18,150 161,212
2026-01-02 Loerop James Chief Business Officer Shares withheld for taxes −6,171 $2.88 $18K 155,041
2026-01-02 Loerop James Chief Business Officer Exercise or conversion · Restricted Stock Units −18,150 18,700
2025-12-31 Loerop James Chief Business Officer Exercise or conversion +73,750 177,056
2025-12-31 Loerop James Chief Business Officer Shares withheld for taxes −33,994 $3.01 $102K 143,062
2025-12-31 Loerop James Chief Business Officer Exercise or conversion · Restricted Stock Units −73,750 0
2025-02-03 Loerop James Chief Business Officer Grant or award · Restricted Stock Units +83,500 83,500
2025-02-03 Loerop James Chief Business Officer Grant or award · Employee Stock Option (Right to Buy) +292,300 292,300

Page 1 of 3 · 53 trades